Rowan Walrath - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Rowan Walrath's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Rowan Walrath

Rowan Walrath

Verified

Associate Editor, C and EN

Boston

Final Covers

health equityCovers: Health

Journalist Type

-

Seniority Positions

Medium Formats

-

Content

Total articles 1640

  • Chemistry majors, set to graduate in May, stress over their futures

    By Laurel Oldach Verified, Krystal Vasquez Verified, Rowan Walrath Verified| C and EN Verified She was excited when the acceptance letter came in January, from a research university in a major East Coast city. "In my brain, I was like, 'Yeah, this is it,' " the student tells C&EN. But in February, when she put together all the offers she had, she began to feel nervous. The offer letter from the research university that was her first choice had promised a contract to follow, but it hadn't yet arrived

    By Laurel Oldach Verified, Krystal Vasquez Verified, Rowan Walrath Verified · C and EN

    Apr. 07, 2025

  • As research funding dries up for US science, few alternatives appear

    By Rowan Walrath Verified| C and EN Verified At UMass Chan Medical School, gene therapy researchers Terence R. Flotte and Robert H. Brown are trying to figure out how to treat amyotrophic lateral sclerosis, the fatal neurodegenerative condition better known as ALS or Lou Gehrig's disease. They've made some progress: antisense oligonucleotides were able to slow down disease progression in at least one patient, and other studies from their labs have helped pin down some genetic causes of the disease, which is still poorly understood

    By Rowan Walrath Verified · C and EN

    Mar. 31, 2025

  • NIH restores some long COVID grants

    By Rowan Walrath Verified| C and EN Verified The US National Institutes of Health (NIH) appears to be reversing course on its decision to abruptly cancel a spate of grants for long COVID research earlier this week. On Friday, the NIH Office of Extramural Research notified an office at New York University (NYU) that funding awarded through the NIH's long COVID research program-Researching COVID to Enhance Recovery, or RECOVER-for pathobiology studies was restored, according to emails shared with C&EN

    By Rowan Walrath Verified · C and EN

    Mar. 28, 2025

As seen in

Company Info

C and EN

Washington, District of Columbia, United States

+1 202-872-4600